[HTML][HTML] The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysis

…, J Onyango, D Kimanga, M Nyangasi… - The Lancet Global …, 2022 - thelancet.com
Background Public health emergencies can disrupt the provision of and access to essential
health-care services, exacerbating health crises. We aimed to assess the effect of the COVID-…

[HTML][HTML] Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey

A Ng'ang'a, M Nyangasi, NG Nkonge, E Gathitu… - BMC public health, 2018 - Springer
Background Cervical cancer is a major public health concern in Kenya. It is the leading
cause of cancer morbidity and mortality among women. Although screening is an effective …

[HTML][HTML] Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019–2020)

V Mwenda, JP Bor, M Nyangasi, J Njeru, S Olwande… - Plos one, 2023 - journals.plos.org
Background Globally, cervical cancer is a major public health problem, with about 604,000
new cases and over 340,000 deaths in 2020. In Kenya, it is the leading cause of cancer …

[HTML][HTML] Cervical cancer programme, Kenya, 2011–2020: lessons to guide elimination as a public health problem

V Mwenda, W Mburu, JP Bor, M Nyangasi… - …, 2022 - ncbi.nlm.nih.gov
Background Cervical cancer is the leading cause of cancer mortality in Kenya, with an
estimated 3,200 deaths in 2020. Kenya has implemented cervical cancer interventions for more …

Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in East Africa

…, F Njuguna, A McLigeyo, M Nyangasi… - The Lancet …, 2023 - thelancet.com
Background Access to essential childhood cancer medicines is a core determinant of childhood
cancer outcomes. Available evidence, although scarce, suggests that access to these …

[HTML][HTML] Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study

V Mwenda, R Jalang'o, C Miano, JP Bor, M Nyangasi… - Vaccine, 2023 - Elsevier
Background Sub-Saharan Africa has the highest rate of cervical cancer cases and deaths
worldwide. Kenya introduced a quadrivalent HPV vaccine (GARDASIL, hereafter referred to as …

[HTML][HTML] Reframing non-communicable diseases and injuries for equity in the era of universal health coverage: findings and recommendations from the Kenya NCDI …

…, A Nganga, D Kiptui, A Karagu, M Nyangasi… - Annals of global …, 2021 - ncbi.nlm.nih.gov
Background: Kenya has implemented a robust response to non-communicable diseases and
injuries (NCDIs); however, key gaps in health services for NCDIs still exist in the attainment …

Breast health awareness campaign and screening pilot in a Kenyan County: Findings and lessons

…, R Njoroge, B Mugi, D Ojuka, M Nyangasi - Cancer …, 2022 - Wiley Online Library
Background and Aim Breast cancer is the leading cancer in terms of incidence in Kenya. We
conducted a breast cancer awareness and screening pilot to assess feasibility of rolling out …

[HTML][HTML] Decentralizing cancer care in sub-Saharan Africa through an integrated regional cancer centre model: The case of Kenya

MF Nyangasi, AA McLigeyo, D Kariuki… - PLOS Global Public …, 2023 - journals.plos.org
For 50 years, comprehensive cancer treatment services were provided at one public hospital
and a few private facilities in the capital city. In 2019, the services were decentralized to …

[HTML][HTML] Mobilizing stakeholders to drive the cervical cancer elimination agenda in Kenya: The national cervical cancer stakeholders' forum 2022

V Mwenda, JP Bor, M Nyangasi, M Temmerman - Dialogues in Health, 2022 - Elsevier
Background Kenya is among the nineteen countries in Sub-Saharan Africa with the highest
burden of cervical cancer globally. The high burden of cervical cancer in developing …